Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

SpaceX's $75B IPO raises questions on retail investor risks amid hype and potential stock drop.

Market News
13 Jun 2026
New York Post
View Source
Neutral
pluang ai news

SpaceX launched the largest IPO ever, raising $75 billion and valuing the company at over $2 trillion. Despite high demand and a fourfold oversubscription, concerns remain about the quality of investors and the sustainability of the stock price after initial gains. The company, which includes AI, satellite, rocket, and social media businesses, reported a $5 billion loss last year, raising doubts about when it will become consistently profitable. Experts warn retail investors to be cautious as the stock may drop significantly after the initial hype fades.

More News

US depends fully on imports for 16 minerals, raising national security risks and investment opportunities.

US depends fully on imports for 16 minerals, raising national security risks and investment opportunities.

The US government has identified 16 minerals it produces none of, making the country 100% reliant on imports for these critical materials, which poses national security and economic risks. Financial expert Jim Rickards highlights this dependency, esp...

Market News
Bullish
1 hour ago
US and Iran likely to sign peace deal within 24 hours, ending months of conflict and easing energy tensions.

US and Iran likely to sign peace deal within 24 hours, ending months of conflict and easing energy tensions.

The US and Iran are expected to finalize a peace agreement within 24 hours, potentially ending over three months of conflict that disrupted global energy supplies and raised gasoline prices. Pakistan's Prime Minister Shehbaz Sharif announced preparat...

Market News
Neutral
3 hours ago
Epcoritamab shows high response rates in elderly diffuse large B-cell lymphoma patients in new trials.

Epcoritamab shows high response rates in elderly diffuse large B-cell lymphoma patients in new trials.

Genmab announced positive Phase 2 and Phase 1b/2 trial results for epcoritamab, a T-cell engaging antibody, in elderly patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) who are ineligible for standard chemotherapy. The Phase 2 trial...

Company Fundamentals
Bullish
3 hours ago
TransCon PTH shows sustained efficacy and safety in hypoparathyroidism over 3.5 years

TransCon PTH shows sustained efficacy and safety in hypoparathyroidism over 3.5 years

Ascendis Pharma announced that its Phase 3 PaTHway Trial data show TransCon PTH maintains long-term efficacy and safety in adults with hypoparathyroidism over 182 weeks. The treatment replicated natural parathyroid hormone effects, improving quality ...

Company Fundamentals
Bullish
4 hours ago
Xi Lai Gaming beats G2 Esports, advances to face EDward Gaming at VCT Masters London 2026

Xi Lai Gaming beats G2 Esports, advances to face EDward Gaming at VCT Masters London 2026

Xi Lai Gaming, a Chinese Valorant team founded in 2023, defeated G2 Esports in a best-of-three series at VCT Masters London 2026, advancing to the upper bracket. This victory sets up a match against EDward Gaming, a familiar rival, with both teams re...

Others
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App